Prevest Denpro Fair Value
Fair Value Analysis Export
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
PREVEST Fair Value Analysis — Data Sources & Coverage
Prevest Denpro financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine PREVEST quarterly trends for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
PREVEST vs Healthcare Sector Peers — P/E, P/B & Market Cap
Prevest Denpro P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 40.04 | 22.87 | ₹8,290 |
| Sat Kartar Shopping | SATKARTAR | 29.05 | 5.53 | ₹307 |
| Sanofi Consumer Healthca… | SANOFICONR | 43.83 | 27.4 | ₹10,638 |
| Accretion Pharmaceuticals | ACCPL | 12.6 | 1.9 | ₹82 |
| Par Drugs & Chemical | PAR | - | 1.21 | ₹132 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.